Cargando…
Synthesis of Moracin C and Its Derivatives with a 2-arylbenzofuran Motif and Evaluation of Their PCSK9 Inhibitory Effects in HepG2 Cells
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key factor in several cardiovascular diseases, as it is responsible for the elevation of circulating low-density lipoprotein cholesterol (LDL-C) levels in blood plasma by direct interaction with the LDL receptor. The development of orally av...
Autores principales: | Masagalli, Jagadeesh Nagarajappa, BasavanaGowda, Melanayakanakatte Kuberappa, Chae, Hee-Sung, Choi, Won Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958322/ https://www.ncbi.nlm.nih.gov/pubmed/33801308 http://dx.doi.org/10.3390/molecules26051327 |
Ejemplares similares
-
Discovery of Flavonoids from Scutellaria baicalensis with Inhibitory Activity Against PCSK 9 Expression: Isolation, Synthesis and Their Biological Evaluation
por: Nhoek, Piseth, et al.
Publicado: (2018) -
Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells
por: Macchi, Chiara, et al.
Publicado: (2021) -
Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study
por: Shrestha, Srijan, et al.
Publicado: (2019) -
Effect of Double Bond Position on 2-Phenyl-benzofuran Antioxidants: A Comparative Study of Moracin C and Iso-Moracin C
por: Li, Xican, et al.
Publicado: (2018) -
Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity
por: Coy-Barrera, Ericsson
Publicado: (2020)